The global market for Compounding Pharmacy is estimated at US$13 Billion in 2023 and is projected to reach US$17.7 Billion by 2030, growing at a CAGR of 3.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Compounding Pharmacy Market]( "Compounding Pharmacy Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Oral Compounded Medicines segment, which is expected to reach US$7.8 Billion by 2030 with a CAGR of 4.5%. The Topical Compounded Medicines segment is also set to grow at 3.7% CAGR over the next 8 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.9 Billion in 2023, and China, forecasted to grow at an impressive 3.7% CAGR to reach $3.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Compounding Pharmacy Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Compounding Pharmacy Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Compounding Pharmacy Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as B. Braun Melsungen AG, Dougherty's Pharmacy, Inc., Fagron NV, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 27 Featured):
- B. Braun Melsungen AG
- Dougherty's Pharmacy, Inc.
- Fagron NV
- Fresenius Kabi AG
- Village Compounding Pharmacy
- Wedgewood Pharmacy
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- Compounding Pharmacy - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Rectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for Ophthalmic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 20: World Historic Review for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 21: World 16-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 23: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 24: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 25: World Compounding Pharmacy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 26: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 27: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 28: World 16-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 29: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 30: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 31: World 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 32: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 33: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 34: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 35: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 36: USA Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 37: USA 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 38: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: USA Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 40: USA 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
CANADA
- Table 41: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 42: Canada Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 43: Canada 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 44: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: Canada Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 46: Canada 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
JAPAN
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 47: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 48: Japan Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 49: Japan 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 50: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: Japan Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 52: Japan 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
CHINA
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 53: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 54: China Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 55: China 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 56: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: China Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 58: China 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
EUROPE
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 59: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 60: Europe Historic Review for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 61: Europe 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 62: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 63: Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 64: Europe 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 65: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 66: Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 67: Europe 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
FRANCE
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 68: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: France Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 70: France 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 71: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 72: France Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 73: France 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
GERMANY
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 74: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: Germany Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 76: Germany 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 77: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 78: Germany Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 79: Germany 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
ITALY
- Table 80: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: Italy Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 82: Italy 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 83: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 84: Italy Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 85: Italy 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 86: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: UK Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 88: UK 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 89: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 90: UK Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 91: UK 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 94: Rest of Europe 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 99: Asia-Pacific Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 100: Asia-Pacific 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF WORLD
- Table 104: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 105: Rest of World Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 106: Rest of World 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
- Table 107: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 108: Rest of World Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 109: Rest of World 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun Melsungen AG
- Dougherty's Pharmacy, Inc.
- Fagron NV
- Fresenius Kabi AG
- Village Compounding Pharmacy
- Wedgewood Pharmacy
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 187 |
| Published | April 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 13 Billion |
| Forecasted Market Value ( USD | $ 17.7 Billion |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
